A mutant form of the ataxin-1 protein with an expanded polyglutamine (polyQ) tract is the underlying cause of the inherited neurodegenerative disease spinocerebellar ataxia 1 (SCA1). In probing the biophysical features of the nuclear bodies (NBs) formed by polyQ-ataxin-1, we defined ataxin-1 NBs as spherical liquid protein/RNA droplets capable of rapid fusion. We observed dynamic exchange of the ataxin-1 protein into these NBs; notably, cell exposure to a pro-oxidant stress could trigger a transition to slower ataxin-1 exchange, typical of a hydrogel state, which no longer showed the same dependence on RNA or sensitivity to 1,6-hexanediol. Furthermore, we could alter ataxin-1 exchange dynamics either through modulating intracellular ATP levels, RNA helicase inhibition, or siRNA-mediated depletion of select RNA helicases. Collectively, these findings reveal the tunable dynamics of the liquid RNA/protein droplets formed by polyQ-ataxin-1.
. In assessing the processes of phase separation and phase transition for other neurodegenerative diseases, it is notable that trinucleotide repeat expansions can be considered as a type of LCR or PrLD 17, 21, 22 . In spinocerebellar ataxia 1 (SCA1) patients, the mutant ATXN1 gene contains CAG repeats that encode an expanded polyglutamine (polyQ) region, and the formation of distinct nuclear "inclusions" of these polyQ-ataxin-1 proteins in SCA1 patients and transgenic mice [23] [24] [25] . Initially these inclusions may lack the fibrillar structure typical of disease-causing amyloids 22, 26 but instead show highly dynamic exchange 27 . The main aim of our study is to provide the first comprehensive evaluation of the physical properties of these NBs, to allow us to define a relationship between NB dynamic exchange and toxicity. Here, we implement a suite of microscopy and biochemical approaches to define the nuclear bodies (NBs) formed by polyQ-ataxin-1 as dynamic liquid protein/RNA droplets. These NBs exhibit ready-to-fuse ability and high dynamics revealed by fluorescence fluctuation spectroscopy (FFS) and fluorescence recovery after photobleaching (FRAP). More importantly, we have observed the tunable dynamics of these ataxin-1 NBs, with their high dynamic liquid phase maintained by ATP and RNA helicases, and their low dynamic hydrogel phase triggered by environmental stress. Thus, models that explain the protein aggregation process and pathogenesis mechanism in SCA1 neurodegeneration should now be extended to include polyQ-ataxin-1 protein phase separation and transition.
Results

PolyQ-ataxin-1 phase separates into liquid droplets in cells. PolyQ proteins can form larger protein
structures that have been implicated as part of their toxicity mechanisms leading to neurodegeneration; this is clearly documented for the polyQ-huntingtin protein that forms heterogeneously-shaped nuclear aggregates 28 . In exploring the physical nature of the larger protein structures formed by polyQ-ataxin-1, we note that ataxin-1 NBs have been observed in SCA1 patients 29 and that GFP-ataxin-1 forms distinctive NBs within the nucleoplasm of different cell lines 30, 31 . Importantly, the remarkably spherical appearance of the ataxin-1[85Q] NBs (Fig. 1A , upper panel) raises the possibility that these NBs arise from phase separation of the ataxin-1[85Q] protein. Phase separation is a phenomenon that gives rise to membrane-less liquid-like compartments that are dependent on protein concentration 11, 32 , are dynamic in composition 9 , and that display increased coordinated movement at the domain boundary due to the free energy cost to leave the compartment phase 33 . Thus, we exploited live cell imaging to explore these properties of the ataxin-1 NBs.
First, we expressed GFP-ataxin-1[85Q] in Neuro-2a cells at different levels by varying the concentrations of the transfected expression plasmid (0.5, 1.0 and 2.0 μg/ml plasmid), noting an increase in ataxin-1 NB size with increased transfected plasmid ( Fig. 1A,B ). To examine exchange dynamics for these ataxin-1 GFP-ataxin-1[85Q] NBs across these transfection conditions (Fig. 1C , rectangles, where I corresponds to NBs with a diameter ≤0.75 μm, II with a 0.75-2 μm diameter, III with a >2 μm diameter), we monitored fluorescence recovery after photobleaching (FRAP) ( Fig. 1D) . A rapid recovery of fluorescence for all NBs indicated a high exchange rate of GFP-ataxin-1[85Q] ( Fig. 1C-E) . Notably, the smaller NBs (group I) showed the fastest initial recovery rates ( Fig. 1E ) achieving near complete recovery within 20 s ( Fig. 1D ). Fluorescence recovery was demonstrated from either within the NB (i.e. non-bleached NB area) or the nucleoplasm surrounding the NB (Supp Fig. 1 ). These observations support our hypothesis that ataxin-1 NBs have liquid-like properties. Furthermore, during our FRAP analyses we frequently observed fusion events in which the movement of GFP-ataxin-1[85Q] NBs through the nucleoplasm brought two spherical NBs into close proximity, followed by their rapid fusion and re-shaping into a single, larger spherical NB (Supp. Fig. 2 and Supp. Movie 1). This observation suggests an ataxin-1 NB domain boundary that spatially confines diffusion, and upon fusion with another NB, undergoes a change in interfacial tension that permits mixing before re-establishment of a larger phase-separated compartment.
To investigate the biophysical properties of the ataxin-1 NB domain boundary and whether it imparts coordinated movement that is disrupted upon fusion with another ataxin-1 NB, we employed fluorescence fluctuation spectroscopy (FFS). Traditionally developed for the detection of protein oligomerisation 34 , a moment-based analysis of the fluctuation in fluorescence intensity recorded in each pixel of a confocal image can detect the localisation of coordinated protein movement in the context of phase separation 33 . Thus, from rapid acquisition of a time series of GFP-ataxin-1[85Q] fluorescence intensity images during a NB fusion event (1000 frames, 120 ms/ frame), we calculated the ratio of the variance (2 nd moment) to the mean (1 st moment) of GFP-ataxin-1[85Q] fluorescence fluctuations recorded in each pixel of 80 frame segments (~10 s) ( Fig. 2A,B ). This analysis enables us to derive a spatial map of where GFP-ataxin-1[85Q] undergoes coordinated movement within a NB (i.e. high variance to mean ratio, Fig. 2C ), and to trace this feature as a function of time during NB fusion ( Fig. 2D ).
As seen in a comparison of the fluorescent intensity images of GFP-ataxin-1[85Q] localization (top row, Fig. 2D ) with the maps of coordinated GFP-ataxin-1[85Q] mobility (bottom row, Fig. 2D ), we observed a high variance to mean ratio only at the NB boundaries. Then, as the two NBs become physically closer and start to fuse, there is a loss of coordinated GFP-ataxin-1[85Q] movement at the point of contact, which results in the high variance to mean ratio localization surrounding a single, larger spherical NB. Interestingly, upon exposure of the cells to an environmental pro-oxidant stress agent such as arsenite 35, 36 , that is well-established for driving formation of the biomolecular condensates known as stress granules [37] [38] [39] , we observe a significant reduction in coordinated GFP-ataxin-1[85Q] mobility at the edge of the NB boundary ( Fig. 2E ). From quantitation of the frequency at indicated time for the indicated ROI. (E) Recovery initial rates (average percentage recovery of fluorescence in the first 15 s) (Fn%/s) were calculated and shown by the pooled data. Each symbol represents a single data point obtained from one ROI across 3 independent experiments. Results represent mean ± SEM (n > 7 measured ROIs). Significance values were calculated by ANOVA, *p < 0.05. which pixels are detected with a high variance to mean ratio in untreated control versus arsenite-treated cells ( Fig. 2F ) and then plotting this parameter as a function of position along a NB axis ( Fig. 2G ), we demonstrate that arsenite treatment results in a five-fold reduction in protein mobility at the NB boundary. Thus, in agreement with the protein concentration ( Fig. 1A,B ) and FRAP (Fig. 1C ,D) analyses, fluorescence fluctuation spectroscopy (FFS) demonstrates a critical phase-separation hallmark for ataxin-1 NBs.
In addition, arsenite treatment not only decreased ataxin-1 NB dynamic exchange, but also increased ataxin-1[85Q] NB size (Supp. Fig. 3 ). Specifically, many larger ataxin-1 NBs were visible (Supp. Fig. 3A ) and quantitative analyses demonstrated a statistically significant increase in average NB size following arsenite treatment (Supp. Fig. 3B ). As the total size of the population of ataxin-1[85Q] NBs per nucleus did not also significantly increase upon arsenite exposure (Supp. Fig. 3C ), these results are consistent with increased fusion of the ataxin-1 NBs in the presence of arsenite. To explore these relationships further, we also examined the behavior of an ataxin-1[85Q] mutant with a deletion in its self-association domain (SAD) 40 (amino acids 495-605, herein termed ataxin-1[85Q]∆SAD) (Supp. Fig. 4 ). In transgenic mice models, polyQ-ataxin-1[77Q]∆SAD was reported as toxic (also tested in Neuro-2a cells as shown in Supp. Fig. 4C ), but without visible NBs 41 . In our cultured Neuro-2a cell system, we observed that ataxin-1[85Q]∆SAD retained the ability to NBs potentially due to the presence of other motifs (such as CT2AXH) outside of the SAD 42 , but these differed from those formed by wild-type ataxin-1[85Q] being significantly smaller in size and not being further impacted by arsenite treatment (Supp. Fig. 4 ). Thus, the formation of ataxin-1[85Q] NBs can be observed in the absence of the reported self-association domain, and when integrated with the previous in vivo studies 41 , these results suggest that these smaller sized NBs may retain the potential for neurotoxicity.
In addition to evaluating the NBs formed by ataxin-1[85Q], we examined the properties of NBs formed by the wild-type ataxin-1[30Q] protein. Expression of GFP-ataxin-1[30Q] protein in Neuro-2a cells showed the formation of spherical NBs indistinguishable morphologically from those observed for GFP-ataxin-1[85Q] (Supp. Fig. 5A ), and consistent with previous studies 43, 44 , thus defining higher ataxin-1 protein concentration as a major contributor to NB formation. Furthermore, ataxin-1[30Q] NBs showed high dynamics (Supp Fig. 5A -C) and fusion (Supp Fig. 5D ) revealed by FRAP and live cell imaging, respectively. Taken together, these results demonstrate ataxin-1 protein phase separation as liquid droplets with high dynamics and fusion.
RNA/transcription is required for polyQ-ataxin-1 phase separation. We next explored the dependence of the formation of ataxin-1 NBs on the presence of RNA, building on previous studies demonstrating an interaction of ataxin-1 with RNA in vitro 45 and also that RNA can contribute to protein phase separation 32, 46 . We addressed this requirement for RNA/transcription in two independent protocols, and we further included an oxidant stress treatment by incubation of the cells in the presence of arsenite 35, 36 . First, we assessed the impact of RNase-mediated degradation on ataxin-1 NBs. Pretreatment with the mild detergent saponin to permeabilise cell and nuclear membranes allowed RNase A access to hydrolyse RNA. Importantly, saponin treatment alone did not impact the ataxin-1 NBs, and so GFP-ataxin-1[85Q] was visualized within distinct NBs (Fig. 3A,   Figure 3 . Ataxin-1 NBs are sensitive to RNase/transcription inhibition in control but not in arsenite stress conditions. Neuro-2a cells were transfected to express GFP-ataxin-1[85Q]. At 24 h post-transfection, cells were treated with arsenite as indicated (A-C), followed by treatment with (A) Saponin only (0.005%, 15 s) for membrane permeabilization, or Saponin + RNase A (100 μg/ml, 1 h, on ice) for RNA degradation, or (B) DMSO only, or Actinomycin D in DMSO (2 μg/ml, 3 h 37 °C). Cells were then fixed and stained with DAPI before CLSM imaging. Zoom images (right panels) correspond to the boxed regions. Representative images are shown from 3 independent experiments. (C) RNA synthesis was detected using imaging including the Click-iT RNA Alexa Fluor 594. 5-ethynyl uridine was added for 24 h before arsenite treatment, then incorporated 5-ethynyl uridine was detected (red). Zoom images (right panels) correspond to the boxed regions. (D) Quantitative analysis of RNA staining intensity ratio (NB area/non-NB area in the nucleoplasm). Each symbol represents a single data point. Results represent the mean ± SEM (n > 10). Significance values were calculated by unpaired two-tailed student's t-test, ***p < 0.001. All scale bars = 10 μm. www.nature.com/scientificreports www.nature.com/scientificreports/ upper two rows). In contrast, saponin followed by RNase A treatment resulted in a diffuse nuclear distribution of GFP-ataxin-1[85Q] for control cells; however, for cells previously treated with arsenite, we noted that the ataxin-1 NBs remained following RNase A treatment (Fig. 3A) . We next considered the impact of the transcriptional inhibitor actinomycin D 47 . In control cells treated with actinomycin D for 3 h, we again noted a diffuse distribution of GFP-ataxin-1[85Q] in the nucleus; but for cells pre-treated with arsenite for 1 h, followed by washout and actinomycin D treatment for 3 h, we continued to observe distinct ataxin-1 NBs (Fig. 3B ). We further examined ataxin-1 NBs for the presence of newly-synthesized RNA 48 . We noted intense staining for RNA throughout the nucleus; this included regions occupied by the GFP-ataxin-1[85Q] nuclear bodies, albeit at levels lower than in the surrounding nucleoplasm; under arsenite-treated conditions, we continued to detect RNA throughout the nucleus, without distinctive accumulation within ataxin-1 NBs (Fig. 3C ). Indeed, quantitative analysis showed that arsenite treatment resulted in lower RNA levels in areas corresponding to the ataxin-1 NBs (Fig. 3D) . These observations support a model in which low RNA levels are critical in initiating liquid droplet formation whereas higher RNA levels trigger droplet disassembly 49, 50 . Thus, ataxin-1 NBs are less reliant on RNA levels when in the presence of arsenite stress.
Different forms of stresses trigger phase transition of liquid ataxin-1 NBs to a reversible or an irreversible hydrogel. The liquid droplets formed by proteins with low complexity region (LCR) or
prion-like domain (PrLD) motifs can show a time-dependent transition through an aging/maturation process 20, 51 . Furthermore, exposure of cells to a range of environmental stress agents, such as arsenite, can enhance stress granule formation [37] [38] [39] . Therefore, we next assessed the impact of arsenite on the maturation/phase transition of ataxin-1 NBs. Our FRAP analyses revealed a significant slowing of GFP-ataxin-1[85Q] maximum recovery and initial rate of recovery, an impact not reversed upon arsenite washout ( Fig. 4) .
We extended our interrogations to include a second environmental insult in the form of hyperosmotic stress induced by addition to the cell culture medium of the non-metabolisable sugar, sorbitol; this change in osmolarity can also promote the formation of cytoplasmic stress granules 52, 53 . We again observed significant slowing of GFP-ataxin-1[85Q] maximum recovery and initial rate of recovery, but these changes could be reversed upon the return of the cells to normal osmotic conditions ( Fig. 4) . Thus, the impact of stress on the transition to form non-dynamic ataxin-1 NBs is dependent on the nature of the initiating stress. This altered physical state of the ataxin-1 NBs does not appear to be caused by altered levels of ataxin-1 expression under these stress conditions, with no significant differences in total fluorescence intensity observed across the control, arsenite, or sorbitol treatments (Supp. Fig. 6 ). To further test the state of the ataxin-1 NBs under different conditions, 1,6-hexanediol, a chemical probe to differentiate liquid-like assemblies from solid-like assemblies 8, 54 , was added to the cells expressing GFP-ataxin-1[85Q] under control or stress conditions (arsenite or sorbitol). Whilst ataxin-1 NBs exhibit a liquid-like state sensitive to 1,6-hexanediol, NBs pre-treated with stress (arsenite but not sorbitol) exhibit a solid-like state as they are 1,6-hexanediol resistant ( Fig. 5 ). Thus, ataxin-1 protein exchange and the properties of ataxin-1 NBs are rapidly responsive to environmental changes.
Maintenance of the ataxin-1 NB liquid phase requires ATP. The maintenance of liquid droplet high dynamics, for membrane-less organelles such as nucleoli, is ATP-dependent 7 . Therefore, we next addressed the ATP requirement in the dynamic exchange of GFP-ataxin-1[85Q] in ataxin-1 NBs. We lowered ATP levels with 2-Deoxy-D-glucose (2DG) and Carbonyl cyanide m-chlorophenyl hydrazone (CCCP) 55, 56 and confirmed ATP recovery upon inhibitor washout (Supp. Fig. 7 ). Strikingly, maximum and initial rates of fluorescence recovery were significantly and irreversibly inhibited by ATP depletion (Fig. 6A-D) , indicating the irreversibility of the phase transition process following ATP depletion.
Down regulation of DEAD/H-box RNA helicases decreases ataxin-1 NB dynamic exchange.
Whilst ATP can directly influence the phase transition process 57, 58 , intracellular ATP levels are also critical for the actions of multiple ATP-dependent enzymes and chaperones 59, 60 . We previously identified 13 RNA helicases in the ataxin-1 interactome (see ProteomeXchange, PXD010352) 61 . RNA helicases have ubiquitous roles in regulating RNA structures as well as RNA-RNA and RNA-protein interactions in multiple different aspects of RNA metabolism, including transcription, mRNA splicing, RNA export, translation and RNA degradation 62, 63 . The two largest groups within the RNA helicase family are the DEAD-box (DDX) and DEAH-box (DHX) helicases 63 . That these RNA helicases may contribute to protein phase transition of membrane-less NBs is seen with siRNA-driven decrease in RNA helicase CGH-1/DDX6 levels resulting in non-dynamic ribonucleoprotein (RNP) granules 64 .
We initially showed that RK-33, an inhibitor that binds the ATP-binding cleft of RNA helicase(s) 65, 66 , could decrease the exchange dynamics of ataxin-1 NBs (Fig. 7) . We next incubated cells in the presence of siRNAs targeting each of the 13 RNA helicases of the ataxin-1 interactome. Our initial FRAP assessments directed our focus to siRNA targeting of the helicases DDX21, DDX19A, DDX42, DDX46, and DHX15. We ensured that the levels of each, as assessed by Western blot, were decreased by siRNA treatment (Supp. Fig. 8 ). Using FRAP protocols, we assessed how these helicase-targeted siRNA treatments, alongside control siRNA treatment, altered the dynamics of recovery. Our quantitative analysis of the pooled data confirmed that DDX42, DDX46, or DDX15 siRNA significantly decreased the dynamic exchange of the ataxin-1 NBs (Fig. 8) by decreasing both the maximum percentage in the bleached area (where 100% represents full recovery) and (D) the initial rate of fluorescence recovery percentage in the bleached area for first three time points (0-15 s of post-bleach). Significance values were calculated by (C) ANOVA or (D) Mann-Whitney and Kruskal-Wallis non-parametric test, n > 7, ****p < 0.0001, ### p < 0.001, n.s. = not significant. All scale bars = 10 μm.
fluorescence recovery (Fig. 8C ) and the initial recovery rate (Fig. 8D ). When we assessed the intracellular localization of each helicase, we further noted that DDX42, DDX46, and DHX15 were more nuclear than cytoplasmic (Supp. Fig. 9A,B) . Taken together, these results reinforce the observation that DDX42, DDX46 and DHX15 are predominantly nuclear RNA helicases that contribute to the regulation of the dynamic exchange of ataxin-1 NBs.
The processes of protein phase transition have been previously discussed as part of a time-dependent or "aging" process that can be linked to neurodegeneration. For example, in ALS, protein condensates formed by FUS or hnRNPA1 can transit to a more solid hydrogel or aggregate phase 8, 9, 19 . Initially this process can be reversed by ATP-dependent chaperones or disaggregases 67 , but the increasing spatial order of these protein assemblies then promotes a transition to a solid-like fibrous aggregate, that may be toxic for neurons and so be a driver of ALS neurodegeneration 14 . We therefore tested the impact of down regulation of RNA helicases on cell viability as an approach to defining whether RNA helicase sequestration/disruption might underpin ataxin-1[85Q]-driven cell toxicity. Treatment of the cells with siRNAs directed to the helicases DDX42, DDX46, or DHX15 that decrease ataxin-1 NBs dynamics (Fig. 8 ) did not significantly increase cell death percentage in GFP-expressing cells, and indeed there was a small but significant increase in viability noted for the DDX42 siRNA-treated GFP-expressing cells (Supp Fig. 10 ). This demonstrates that a disruption of RNA helicases, and in particular the single disruption of DDX42, DDX46 or DHX15, is not a toxic event per se, but it also further suggests a decreased dynamics of ataxin-1[85Q] NBs that is observed upon the down regulation of specific RNA helicases is not caused by reduced cell viability.
Arsenite increases ataxin-1[85Q]S776A toxicity and decreases ataxin-1[85Q]S776A NB dynamic exchange.
To further explore any correlation between NB size and dynamics and cell toxicity, an ataxin-1 S776A mutant (ataxin-1 serine 776 mutated to the non-phosphorylatable alanine) 68, 69 was examined ( Fig. 9 ). Indeed, ataxin-1[85Q]S776A remained non-toxic under control conditions as reported 68, 69 with levels of cell death being not statistically different from those recorded for GFP-only transfected cells (Fig. 9A ). However, upon arsenite treatment, we observed statistically significant increases in death of cells expressing GFP-only, GFP-ataxin-1[85Q] or GFP-ataxin-1[85Q]S776A such that toxicity for cells expressing either form of ataxin-1 was comparable (Fig. 9A ). When we examined the morphology of ataxin-1 protein exchange for the NBs formed, we observed that ataxin-1[85Q]S776A formed smaller NBs that did not increase in size upon arsenite treatment (Fig. 9B ). This suggests that size of the formed NB cannot itself be used as a predictor of toxicity, and thus we further considered the dynamics of these NBs, noting the similar level of high dynamics of ataxin-1 exchange for both the ataxin-1[85Q] and ataxin-1[85Q]S776A NBs, and with the dynamic exchange of both significantly slowing upon arsenite exposure ( Fig. 9E-G) . These results suggest that decreased NBs dynamics may be related to enhanced cytotoxicity, but this interpretation may be complicated by the broad spectrum of impacts of arsenite exposure [35] [36] [37] [38] [39] .
Discussion
Proteins with LCR or PrLD have attracted much recent attention due to their ability to phase separate to liquid droplets and transition to disease-associated non-dynamic aggregates 8, 9, 19 . Here we interrogate polyQ-ataxin-1 NBs in cells to show, for the first time, their multiple liquid-like properties and phase transition to structures with lower dynamic exchange. Based on our findings of NB fusion and the altered protein exchange dynamics we propose a model, as depicted in Fig. 10 , in which the ataxin-1 protein undergoes phase separation and then transitions via the liquid droplet state to ultimately form a less dynamic state typical of a hydrogel. In the following paragraphs, we discuss key features of this model and its integration with the current concepts of the formation of biomolecular condensates and the reported physical features and toxicity of polyQ proteins.
Initially, the formation of NBs is favoured by an increased concentration of the ataxin-1 protein itself ( Fig. 1) . Whilst proteins at low concentrations show diffuse intracellular distributions, phase separation can be observed when a critical threshold concentration intrinsic to each protein is exceeded 8, [11] [12] [13] 19 . This concentration-dependent phase separation has been reported for multiple LCR/PrLD-containing proteins, including ALS disease-causing proteins FUS, hnRNPA1, TIA1, and polyQ protein WHI3 12 ; because the polyQ tract is a predicted PrLD 21,22 , polyQ-ataxin-1 is expected to behave in this way in cells. Consistent with previous reports 70 , here we have shown that both mutant polyQ-ataxin-1 (with an expanded polyQ tract) and wild-type ataxin-1 protein (with a shorter polyQ tract) can form NBs (Fig. 1 and Supp. Fig. 3 ). Importantly, although the toxic form of ataxin-1 was first identified with an expanded polyQ tract 23, 71 , increased expression of even the wild-type ataxin-1 causes SCA1 phenotypic changes in flies and mice models 43, 44 . Thus, increased ataxin-1 protein levels are important in the toxicity mechanisms in SCA1 and a significant consequence of an expanded polyQ www.nature.com/scientificreports www.nature.com/scientificreports/ tract is increased stability that favours the accumulation of higher levels of ataxin-1 72 and thus the formation of ataxin-1 NBs.
RNA also contributes to the processes of phase separation for ataxin-1 as demonstrated by our results showing the impact of RNase treatment or actinomycin D exposure to drive diffuse distribution of the ataxin-1 protein mainly in the nucleus (Fig. 3) . Whilst RNA alone can undergo phase separation into liquid droplets 10 , RNA can also change the material properties of protein assemblies to influence phase separation and transition 12, 32, 73 . Ataxin-1's ability to interact with RNA in vitro has been reported as showing strong binding to poly(rG) but weaker binding to poly(rU), poly(rA), and poly (rC) 45 . Our bioinformatics assessment of the ataxin-1 interactome 61 highlights a link of ataxin-1 to the processes of RNA metabolism and specifically identified multiple RNA helicases. Our identification of the RNA helicases DDX42, DDX46, and DHX15 which function in pre-mRNA processing [74] [75] [76] as regulators of ataxin-1 NBs dynamics ( Figs. 7 and 8 ) reinforces a functional association of ataxin-1 with RNA metabolism 68, 77 .
We also characterized the liquid droplet state of the ataxin-1 NBs (Figs. 1 and 2) . Importantly, our FFS analyses revealed that the ataxin-1 NB boundary imparts coordinated movement and that upon fusion of two individual ataxin-1 NBs the interfacial tension established by this boundary is disrupted such that mixing between the two compartments is permitted and a single larger NB is formed. The application of FFS to quantify molecular 33, 78, 79 . By capitalizing on the capacity of FFS to detect the localisation of coordinated protein movement, we recover a map that reports the coordinated movement of ataxin-1 in and out of the NB, which can be tracked as a function of time and modified by arsenite stress (Fig. 2) . Thus, FFS should be considered a critical inclusion in the approaches to study biomolecular condensates.
Importantly, our use of FRAP protocols revealed the tunable dynamics of ataxin-1 exchange for these NBs; exchange under control conditions was rapid, but multiple factors could slow this exchange. This reinforces the concepts of phase transition in which liquid-like condensates show rapid fusion and high dynamics, but then the processes of phase transition result in the formation of non-dynamic hydrogels, and ultimately solid-like fibrous aggregates, characterized by a higher spatial order of protein structures and decreased exchange dynamics with their environment 14 . For ataxin-1 NBs, we showed that this characteristic of the phase transition process could be promoted by the exposure of the cells to different forms of environmental stress (Figs. 4 and 5) or ATP depletion (Fig. 6) . These changes echo the observations of previous studies that highlighted a maturation of dynamic ataxin-1 NBs over time to result in mixed populations with slow-or fast-exchanging components 70 , and support the notion that external factors such as temperature, pH, salinity, oxidative stress or osmolarity can promote phase separation and transition 12, 80 . The application of arsenite or sorbitol stress is known to induce the formation of the biomolecular condensates known as stress granules [37] [38] [39] 52, 53 by causing pro-oxidative or hyperosmotic stress responses, respectively, that ultimately stall protein translation 37, 53 . Here we have noted a striking difference for ataxin-1 NBs: the transition to the non-dynamic hydrogel state is irreversible if initiated by arsenite, but reversible if initiated by osmotic stress. The exact mechanisms underlying these differences require further evaluation, but may reflect irreversible oxidative damage in the presence of arsenite, but reversible osmotic control via water efflux and influx 81 when osmolarity is modulated by the presence of different concentrations of sorbitol.
Our study has provided the first comprehensive evaluation of the physical properties of these NBs (Figs. 1-6) , evaluating a suite of manipulations that allow us to define a relationship between NB dynamic exchange and toxicity ( Figs. 7, 8 , Supp. Figs. 9 and 10 ). Thus, we propose that possible links between the regulation of ataxin-1 NB dynamics and the neurodegeneration observed in SCA1 patients should be an important area for future investigation. A dynamic exchange in the liquid droplet stage of the ataxin-1 NB formation would not restrict the transport of associated proteins into and/or exiting the NB 27 ; thus ataxin-1 NBs are disassembled during mitosis and then ataxin-1 protein can be re-distributed into two cells 82 . With the phase transition to an irreversible hydrogel as that caused by ATP depletion or arsenite stress, it is inevitable that cellular function would be impacted if additional proteins essential for normal cellular functions are sequestered. Current SCA1 murine models (e.g. SCA1[82Q] transgenic mice [83] [84] [85] or SCA1[154Q/2Q] knock-in mice [86] [87] [88] ) rely on the assessment of downstream pathological impacts but, to date, have not included fluorescent protein tagging of the expressed polyQ-ataxin-1 protein. Thus, future studies in murine SCA1 models engineered to express fluorescent protein-tagged polyQ-ataxin-1 will enable the study of the dynamics of ataxin-1 NBs in Purkinje cells, for example by capitalizing on recent advances in lattice light sheet microscopy that offer advantages in spatial and temporal resolution as well as low phototoxicity 89, 90 . The polyQ-ataxin-1 phase transition model that we propose ( Fig. 10 ) will thus provide a framework for ongoing investigations to contribute new knowledge to a mechanistic understanding how polyQ-ataxin-1 can drive the pathological changes observed in the neurodegenerative disease SCA1. Cells transfected to express GFP-ataxin-1 proteins were subjected to different treatments as follows. For environmental stress, cells were exposed to either the pro-oxidant stress of arsenite (0.3 mM, 1 h, 37 °C) (Sigma), whereas for hyperosmotic stress cells were exposed to the non-metabolisable sugar D-sorbitol (0.5 M, 1 h, 37 °C) (Ajax Finechem). For RNase treatment, cells were treated with saponin (0.005%, 15 s, room temperature) (Sigma) prior to the addition of RNase A (100 μg/ml, 1 h, ice) (Invitrogen); thus, saponin-only treatment was employed in parallel control studies. For transcription inhibition, cells were exposed to actinomycin D (2 μg/ml, 3 h, 37 °C) (Sigma), with an equivalent exposure to only the vehicle DMSO (0.2%, 3 h, 37 °C) (Merck), as a negative control. For 1,6-hexanediol treatment, cells were incubated with 5% 1,6-hexanediol (5 min, RT) (Sigma) prior to cell fixation. For RK-33 treatment, cells were treated with 20 μM or 40 μM RK-33 (Adooq, A16194) (24 h, 37 °C) 4 h percentage in the bleached area (where 100% represents full recovery) and (D) the initial rate of fluorescence recovery percentage in the bleached area for first three time points (0-15 s of post-bleach). Significance values were calculated by ANOVA, n > 10, *p < 0.05, **p < 0.01, **** p < 0.0001, n.s. = not significant. All scale bars = 6 μm.
Materials and Methods
Immunostaining. Neuro-2a cells were cultured on coverslips (Proscitech) within 12-well plates, transfected and treated with 0.3 mM arsenite, as indicated. Subsequent processing was performed in phosphate-buffered saline at room temperature as follows: washing, permeabilization (0.2% (v/v) Triton X-100), fixation (4% (w/v) paraformaldehyde) and blocking (1% (w/v) bovine serum albumin (BSA)). Cells were incubated sequentially with primary antibodies then fluorophore-conjugated secondary antibodies as indicated, each in 1% (w/v) BSA in phosphate-buffered saline (PBS) for 1 h at room temperature: anti-DDX19A (Abcam, ab108462) Confocal laser scanning microscopy (CLSM) and image analysis. Fixed samples were visualized by confocal laser scanning microscopy (CLSM) (Leica TCS SP5 with 63X 1.4 Oil Objective). All imaging studies were performed on >3 independent occasions including preliminary optimization steps. The acquired images were quantitatively analyzed using CellProfiler cell image analysis software (version 2.1.1 for Mac) for ataxin-1 NB size (μm 2 ; the size of individual NBs as well as the total size of NBs per nucleus calculated by summing the size of all individual NBs within a nucleus) and the fluorescence intensity of nucleus/cytoplasm ratio (Fn/c) for localization of RNA helicases. In the Fn/c analyses, after applying the "CorrectIllumination" function, cytoplasmic areas were defined by subtracting the area stained with DAPI. Where indicated, acquired images were quantitatively analyzed using Fiji for fluorescence intensity of RNA staining within NBs/non-NBs or total nuclear fluorescence intensity (pixels). Quantitation of the RNA fluorescence ratio of NB/non-NB was calculated using the formula: (F NB − F background )/(F non-NB − F background ), in which F NB represents average RNA fluorescence intensity in the NB area, F non-NB represents average RNA fluorescence intensity in the non-NB area in the nucleoplasm and F Background represents average RNA fluorescence intensity in the background of the image.
Live cell imaging, fluorescence recovery after photobleaching (FRAP) and fluorescence fluctuation spectroscopy (FFS).
At 24 h post-transfection, culture medium was replaced with pre-warmed Phenol-Red-Free DMEM growth medium (Gibco). Cells were kept in an environmental chamber (37 °C, 5% CO 2 ) throughout live cell imaging, as well as the FRAP and FFS acquisitions. Image stacks acquired during GFP-ataxin-1 NB fusion events or FRAP analysis were collected using the CLSM Leica TCS SP5 (63X 1.4 Oil Objective). Images stacks acquired during GFP-ataxin-1 NB fusion events and subsequent fluorescence fluctuation analysis were collected using the Zeiss Elyra 780 (63X 1.2 Water Objective).
For FRAP, GFP was excited with the 488 nm emission line of an Argon laser with maximum laser power (50% for Leica TCS SP5) lasting one frame used for photobleaching. Three frames were recorded before photobleaching at a minimal interval (1.3 s). Fluorescence recovery was recorded at 5 s intervals for 250 s. Fluorescence intensity was measured using Fiji. Recovery curve fitting and maximum fluorescence recovery were calculated in SigmaPlot 12.0. Initial rate was calculated as the average fluorescence recovery rate for the first 15 s.
For FFS, 1000 frames (64 × 64 pixel) were acquired using a digital zoom of 10 (13.5 μm region of interest) and a 12. Protein samples were separated by SDS-PAGE (8% polyacrylamide gels, 1.5 h) and transferred to polyvinylidene difluoride (PVDF) membranes (Amersham Life Science; 2 h, room temperature). Subsequent steps were performed by blocking with 1% (w/v) BSA in phosphate-buffered saline (PBS; 0.5 h, room temperature), and incubating with primary antibodies (all anti-DDX antibodies as per those used in immunofluorescence analyses) and horseradish peroxidase-linked secondary antibodies (ThermoFisher Scientific) (1:1000) for visualization using an enhanced chemiluminescence detection system (ThermoFisher Scientific). Images were captured using ChemiDoc imager (Bio-Rad) operating in a single-channel protocol.
Cell death assessment. Neuro-2a cells (2 × 10 5 cells/well) with transfection as indicated in different conditions, were suspended in PBS and transferred to 5 ml glass round-bottom tubes (BD Bioscience). To determine the numbers of dead cells per sample, the SYTOX Red dead cell stain (ThermoFisher Scientific) was added to cell suspensions, and incubated at room temperature for 15 min before flow cytometry analysis according to the manufacturer's instructions. All samples were prepared and measured in triplicate, with n = 3 independent experiments performed.
Fluorescence detection and recording was assessed by flow cytometry (BD LSRFortessa (BD Bioscience)) with the background fluorescence control estimated from using untransfected cells and negative controls determined by the GFP-only cells (GFP, Green channel) and SYTOX-only cells (SYTOX, Red channel). The voltage applied to each channel was adjusted according to the GFP-only or SYTOX-only controls to avoid the fluorescence count exceeding 100 K. For analysis, 50,000-75,000 cells were recorded by the cytometer for each sample. FlowJo software (Version vX.0.7) was used in the analysis. The gating of debris and intact Neuro-2a cells was based on forward scatter-height (FSC-H) and the dead cell stain (APC-A). Further gating of single cells was based on the side scatter-height (SSC-H) and side scatter-width (SSC-W) or FSC-H and forward scatter-width (FSC-W). The gating for transfected cells was based on fluorescence GFP-A (GFP, Green channel); the gate for dead cells was based on fluorescence APC-A (SYTOX, Red channel). Cell death percentage (%) in each fluorescence range was determined using the following formula: Number of 100 × (dead cells/number of total cells).
Statistical analysis. Graphpad Prism 6 (version 6.00 for Mac) was used for statistical analysis. Data are represented as mean ± standard error of the mean (SEM). Data sets were analyzed by D' Agostino-Pearson omnibus normality test before further comparison analysis. For datasets with normal distribution, an unpaired two-tailed Figure 10 . Model showing the multiple factors contributing to the tunable dynamics of ataxin-1 NBs. Ataxin-1 can transit through three stages: diffuse nuclear protein, liquid droplet and then hydrogel, with multiple factors controlling these transitions. Initially, perturbations in ataxin-1 protein level or RNA/transcription, or by 1,6-hexanediol, can influence the transition from diffuse protein to dynamic liquid droplets that are visualized as distinct spherical ataxin-1 NB; fusion can result in larger NBs, but additional factors of time, altered RNA helicases by inhibitor RK-33 or siRNA, ATP depletion, or environmental stresses impact these ataxin-1 NBs to establish a less exchange dynamic and molecular fluctuation hydrogel state.
